PF-06863135 Uses, Dosage, Side Effects and more
PF-06863135 is under investigation in clinical trial NCT03269136 (Phase 1 Study Of PF-06863135, A BCMA- CD3 Bispecific Ab, In Relapse/ Refractory Multiple Myeloma).
| Trade Name | PF-06863135 |
| Generic | PF-06863135 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
